Literature DB >> 3052262

PA-1, a human cell model for multistage carcinogenesis: oncogenes and other factors.

M A Tainsky1, D B Krizman, P J Chiao, S O Yim, B C Giovanella.   

Abstract

We have developed a cell system which utilizes the human teratocarcinoma cell line PA-1, from which we have characterized four stages of tumor progression. Soon after establishment in culture PA-1 cells revert and are no longer tumorigenic in athymic nude mice. Later, PA-1 cells as they are passaged in culture, become tumorigenic at passage 100. The transition from nontumorigenic to tumorigenic is the result of the biological effects of an activated N-ras oncogene and can be reproduced by transfection of the cloned oncogene into preneoplastic PA-1 cells. Certain preneoplastic cells (prior to passage 100) in this series are susceptible to transformation by single oncogenes while others are not. In studying the basis of this susceptibility to single oncogene induced transformation we have found that somatic cell hybrids between preneoplastic cells which can suppress ras-induced transformation and ras-transformed cells are non-tumorigenic. Therefore, we believe that the progression from ras suppressing to ras susceptibility may be due to the inactivation of a trans-dominant suppressor gene. Our system has identified at least three steps which lead to tumorigenicity; establishment of growth past senesence, activation of a ras oncogene, and inactivation of an oncogene suppressor function. Further genetic alterations are necessary for tumor dissemination and metastasis.

Entities:  

Mesh:

Year:  1988        PMID: 3052262

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  PARI overexpression promotes genomic instability and pancreatic tumorigenesis.

Authors:  Kevin W O'Connor; Donniphat Dejsuphong; Eunmi Park; Claudia M Nicolae; Alec C Kimmelman; Alan D D'Andrea; George-Lucian Moldovan
Journal:  Cancer Res       Date:  2013-02-22       Impact factor: 12.701

2.  Alteration of homeobox gene expression by N-ras transformation of PA-1 human teratocarcinoma cells.

Authors:  R Buettner; S O Yim; Y S Hong; E Boncinelli; M A Tainsky
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2.

Authors:  R Buettner; P Kannan; A Imhof; R Bauer; S O Yim; R Glockshuber; M W Van Dyke; M A Tainsky
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

Review 4.  The current state of oncogenes and cancer: experimental approaches for analyzing oncogenetic events in human cancer.

Authors:  P J Chiao; F Z Bischoff; L C Strong; M A Tainsky
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

5.  The genomic structure of the human AP-2 transcription factor.

Authors:  R Bauer; A Imhof; A Pscherer; H Kopp; M Moser; S Seegers; M Kerscher; M A Tainsky; F Hofstaedter; R Buettner
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

6.  Identification of a retinoic acid-inducible endogenous retroviral transcript in the human teratocarcinoma-derived cell line PA-1.

Authors:  P Kannan; R Buettner; D R Pratt; M A Tainsky
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Coactivator PC4 mediates AP-2 transcriptional activity and suppresses ras-induced transformation dependent on AP-2 transcriptional interference.

Authors:  P Kannan; M A Tainsky
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

8.  A novel styryl diphenylamine derivative reverts the transformed phenotype of human fibrosarcoma HT1080 cells.

Authors:  I Ohizumi; M Tanemura; S Kaihoh
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.